Science Corp. to Begin Human Trials for Biohybrid Brain-Computer Interface
Science Corporation, led by Max Hodak, is preparing to conduct its first human trials for a biohybrid brain-computer interface, with Dr. Murat Günel as a scientific adviser. The company, valued at $1.5 billion after a $230 million Series C round, is advancing its PRIMA device for vision restoration and aims to develop interfaces that combine lab-grown neurons with electronics for both medical and enhancement purposes.
Topics: Brain-Computer Interface Clinical Trials Medical Innovation Neurotechnology Startup Funding